CoChat

Rationale and design of WEBCARE: A randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of life

Open access
Pedersen, Susanne S, Spek, Viola, Theuns, Dominic AMJ, Alings, Marco, van der Voort, Pepijn, Jordaens, Luc, Cuijpers, Pim, Denollet, Johan, van den Broek, Krista C · 2009 · Trials
Cited by 32

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The implantable cardioverter defibrillator (ICD) is generally well accepted, but 25-33% of patients experience clinical levels of anxiety, depression, and impaired quality of life (QoL) following implantation. Few trials in ICD patients have investigated whether behavioral intervention may mitigate the development of these adjustment problems. We present the rationale and study design of the WEB-based distress management program for implantable CARdioverter dEfibrillator patients (WEBCARE) trial. METHODS: WEBCARE is a multi-center, multi-disciplinary, randomized, controlled behavioral intervention trial designed to examine the effectiveness of a web-based approach in terms of reducing levels of anxiety and device concerns and enhancing QoL. Consecutive patients hospitalized for the implantation of an ICD will be approached for study participation while in hospital and randomized to the intervention arm (n = 175) versus usual care (n = 175) at baseline (5-10 days post implantation). Patients will complete assessments of patient-centered outcomes at baseline, 14, 26, and 52 weeks after implantation. Patients randomized to the intervention arm will receive a 12-week web-based behavioral intervention starting 2 weeks after implantation. Primary endpoints include (i(i)) patient-centered outcomes (i.e., anxiety, depression, ICD acceptance, QoL); (i(ii)) health care utilization; and (i(iii)) cost-effectiveness. All primary endpoints will be assessed with standardized and validated disease-specific or generic questionnaires. Secondary endpoints include (ii(i)) cortisol awakening response; and (ii(ii)) ventricular arrhythmias. DISCUSSION: WEBCARE will show whether a behavioral intervention using a web-based approach is feasible and effective in reducing anxiety and ICD concerns and improving QoL in ICD patients. TRIAL REGISTRATION: http://www.ClinicalTrials.gov. Identifier: NCT00895700.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1745-6215-10-120

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 26

  1. Crespo EM, Kim J, Selzman KA: The use of implantable cardioverter defibrillators for the prevention of sudden cardiac death: a review of the evidence and implications. Am J Med Sci. 2005, 329: 238-246. 10.1097/00000441-200505000-00005. · DOI
  2. Seidl K, Senges J: Worldwide utilization of implantable cardioverter/defibrillators now and in the future. Card Electrophysiol Rev. 2003, 7: 5-13. 10.1023/A:1023603118860. · DOI
  3. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y, American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics -- 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009, 119: e21-e181. 10.1161/CIRCULATIONAHA.108.191261. · DOI · Paper page
  4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002, 346: 877-883. 10.1056/NEJMoa013474. · DOI · Paper page
  5. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004, 350: 2140-2150. 10.1056/NEJMoa032423. · DOI · Paper page
  6. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005, 352: 225-237. 10.1056/NEJMoa043399. · DOI · Paper page
  7. Johansen JB, Pedersen SS, Spindler H, Andersen K, Nielsen JC, Mortensen PT: Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients. Europace. 2008, 10: 545-551. 10.1093/europace/eun073. · DOI
  8. Matchett M, Sears SF, Hazelton G, Kirian K, Wilson E, Nekkanti R: The implantable cardioverter defibrillator: its history, current psychological impact and future. Expert Rev Med Devices. 2009, 6: 43-50. 10.1586/17434440.6.1.43. · DOI
  9. Broek Van den KC, Nyklicek I, Van der Voort PH, Alings M, Denollet J: Shocks, personality, and anxiety in patients with an implantable defibrillator. Pacing Clin Electrophysiol. 2008, 31: 850-857. 10.1111/j.1540-8159.2008.01099.x. · DOI
  10. Pedersen SS, Theuns DA, Muskens-Heemskerk A, Erdman RA, Jordaens L: Type D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation. Europace. 2007, 9: 675-680. 10.1093/europace/eum041. · DOI · Paper page
  11. Sears SF, Conti JB: Quality of life and psychological functioning of ICD patients. Heart. 2002, 87: 488-493. 10.1136/heart.87.5.488. · DOI · Paper page
  12. Pedersen SS, Theuns DA, Erdman RA, Jordaens L: Clustering of device-related concerns and type D personality predicts increased distress in ICD patients independent of shocks. Pacing Clin Electrophysiol. 2008, 31: 20-27. 10.1111/j.1540-8159.2008.01158.x. · DOI
  13. Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RA: Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J. 2005, 149: 664-669. 10.1016/j.ahj.2004.06.031. · DOI · Paper page
  14. Broek Van den KC, Denollet J, Nyklicek I, Voort Van der PH: Psychological reaction to potential malfunctioning of implantable defibrillators. Pacing Clin Electrophysiol. 2006, 29: 953-956. 10.1111/j.1540-8159.2006.00468.x. · DOI · Paper page
  15. Whang W, Albert CM, Sears SF, Lampert R, Conti JB, Wang PJ, Singh JP, Ruskin JN, Muller JE, Mittleman MA, TOVA Study Investigators: Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol. 2005, 45: 1090-1095. 10.1016/j.jacc.2004.12.053. · DOI · Paper page
  16. Dunbar SB, Kimble LP, Jenkins LS, Hawthorne M, Dudley W, Slemmons M, Langberg JJ: Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety. 1999, 9: 163-168. 10.1002/(SICI)1520-6394(1999)9:4<163::AID-DA3>3.0.CO;2-B. · DOI
  17. Weber CS, Thayer JF, Rudat M, Sharma AM, Perschel FH, Buchholz K, Deter HC: Salt-sensitive men show reduced heart rate variability, lower norepinephrine and enhanced cortisol during mental stress. J Hum Hypertens. 2008, 22: 423-431. 10.1038/jhh.2008.11. · DOI
  18. Pedersen SS, Broek van den KC, Sears SF: Psychological intervention following implantation of an implantable defibrillator: a review and future recommendations. Pacing Clin Electrophysiol. 2007, 30: 1546-1554. · DOI · Paper page
  19. Sears SF, Sowell LD, Kuhl EA, Kovacs AH, Serber ER, Handberg E, Kneipp SM, Zineh I, Conti JB: The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing Clin Electrophysiol. 2007, 30: 858-864. 10.1111/j.1540-8159.2007.00773.x. · DOI
  20. Lewin RJ, Coulton S, Frizelle DJ, Kaye G, Cox H: A brief cognitive behavioural preimplantation and rehabilitation programme for patients receiving an implantable cardioverter-defibrillator improves physical health and reduces psychological morbidity and unplanned readmissions. Heart. 2009, 95: 63-69. 10.1136/hrt.2007.129890. · DOI
  21. Pedersen SS, Denollet J: Is Type D personality here to stay? Emerging evidence across cardiovascular disease patient groups. Curr Cardiol Rev. 2006, 2: 205-213. 10.2174/157340306778019441. · DOI · Paper page
  22. Denollet J: DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med. 2005, 67: 89-97. 10.1097/01.psy.0000149256.81953.49. · DOI · Paper page
  23. Kuhl EA, Dixit NK, Walker RL, Conti JB, Sears SF: Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. Pacing Clin Electrophysiol. 2006, 29: 614-618. 10.1111/j.1540-8159.2006.00408.x. · DOI
  24. Rector TS, Kubo SH, Cohn JN: Patient's self-assessment of their congestive heart failure. Content, reliability, and validity of a new measure: the Minnesota Living with Heart Failure Questionnaire. Heart Failure. 1987, 10: 198-209.
  25. Burns JL, Serber ER, Keim S, Sears SF: Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey. J Cardiovasc Electrophysiol. 2005, 16: 384-390. · DOI · Paper page
  26. Pedersen SS, Spindler H, Johansen JB, Mortensen PT, Sears SF: Correlates of patient acceptance of the cardioverter defibrillator: cross-validation of the Florida Patient Acceptance Survey in Danish patients. Pacing Clin Electrophysiol. 2008, 31: 1168-1177. 10.1111/j.1540-8159.2008.01158.x. · DOI

Cited by

See all 32

Metadata

Authors
Pedersen, S. S., Spek, V., Theuns, D. A., Alings, M., van der Voort, P., Jordaens, L., Cuijpers, P., Denollet, J., & van den Broek, K. C.
Venue
Trials
Published
2009-12
Volume
10
Issue
1
Pages
120-120
ISSN
1745-6215 (ISSN-L)
OpenAlex
W2113513690
Cited by
32
References
10
FWCI
2.77
Type
journal article
Language
en
Open access
gold
Licence
creativecommons.org/licenses/by/2.0 (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rationale and design of WEBCARE: A randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of life. https://app.cochat.ai/papers/10.1186/1745-6215-10-120
The paper
Pedersen, S. S., Spek, V., Theuns, D. A., Alings, M., van der Voort, P., Jordaens, L., Cuijpers, P., Denollet, J., & van den Broek, K. C. (2009). Rationale and design of WEBCARE: A randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of life. Trials. https://doi.org/10.1186/1745-6215-10-120

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.